IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ENLV

Balance Sheet

(in billions USD)
MetricQ4 2025Q2 2025Q4 2024Q2 2024Q4 2023Q2 2023Q4 2022Q2 2022Q4 2021Q2 2021
Cash & Equivalents0.000.000.000.000.000.000.050.020.010.01
Short-term Investments--0.000.000.000.010.03--0.060.060.07
Total Current Assets1.740.020.030.030.030.030.050.070.090.09
Property, Plant & Equipment0.000.000.000.000.000.010.010.010.000.00
Total Non-current Assets0.580.000.000.000.000.020.020.010.010.00
Total Assets2.330.020.030.030.040.050.070.080.100.10
Accounts Payable------0.00------------
Short-term Debt----------0.03--0.04--0.01
Total Current Liabilities0.010.000.000.000.010.000.010.000.000.00
Long-term Debt----------0.01--------
Total Non-current Liabilities0.380.000.000.000.000.000.000.000.010.00
Total Liabilities0.390.000.000.000.010.010.010.010.010.00
Retained Earnings1.11(0.13)(0.13)(0.12)(0.11)(0.10)(0.08)(0.07)(0.05)(0.04)
Total Stockholder Equity1.930.020.020.030.030.040.060.070.090.09
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Research & Development2.142.005.044.112.54
Selling, General & Admin0.940.991.611.761.27
Total Operating Expenses3.082.996.655.873.81
Operating Income(3.08)(2.99)(6.65)(5.87)(3.81)
Interest Expense------8.907.60
Net Income(1.87)(3.10)(6.79)(9.91)(3.11)
Basic EPS(1.28)(2.56)(5.92)(8.64)--
Diluted EPS(1.28)(2.56)(5.92)(8.64)--
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2023Q2 2022Q2 2021
Operating Cash Flow(5.82)(6.31)(12.81)(12.54)(6.75)
Capital Expenditures0.040.060.204.350.47
Free Cash Flow*(5.86)(6.37)(13.01)(16.89)(7.22)
Investing Cash Flow4.244.30(34.05)21.36(47.39)
Financing Cash Flow0.204.940.360.1060.92
← Scroll for more columns →

* Derived from reported values